Hepatocellular Carcinoma Registry for Turkey (3K Trial)
Profile of the Hepatocellular Carcinoma Patients in Turkey
Sponsor: Bayer
A observational or N/A phase clinical study on Hepatocellular Carcinoma, this trial is completed. The trial is conducted by Bayer and has accumulated 14 data snapshots since 2012. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Aug 2019 — Jan 2021 [monthly]
Completed
▶ Show 9 earlier versions
-
Oct 2018 — Aug 2019 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Aug 2018 — Oct 2018 [monthly]
Active Not Recruiting
-
Jul 2018 — Aug 2018 [monthly]
Active Not Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Dec 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Oct 2017 — Dec 2017 [monthly]
Active Not Recruiting NA
-
Jun 2017 — Oct 2017 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Jun 2017 [monthly]
Active Not Recruiting NA
First recorded
Aug 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bayer
For direct contact, visit the study record on ClinicalTrials.gov .